Some clinicians are concerned by these results, while some people say a diagnosis brought validation and life-changing help.
Psychiatrists and GPs are warning that the safety of ADHD patients is threatened by the Victorian government’s plan to allow ...
From nausea and exhaustion to emotional shifts and social awkwardness, people on GLP-1 medications are sharing the side effects they didn't expect — and rarely see talked about.
New rules allowing GPs and nurse practitioners to prescribe drugs to treat ADHD increase the risk of over-diagnosis, over-prescribing, addiction, psychosis and other harms, some clinicians are warning ...
From nausea and exhaustion to emotional shifts and social awkwardness, people on GLP-1 medications are sharing the side ...
While safe, external trigeminal nerve stimulation does not show clinical efficacy for ADHD in children and adolescents.
The majority of these patients (54%) agree that genetic testing for mental health medications (known as pharmacogenomic or PGx testing) could reduce these concerns. “It’s encouraging to see patients ...
Diagnoses of attention deficit hyperactivity disorder (ADHD) are rising rapidly in the U.K. More children and teenagers than ever are being referred for assessment and support, and families are often ...
A larger trial of trigeminal nerve stimulation in children with ADHD produce results that differ from an earlier pilot study, raising new questions about its efficacy.
MedPage Today on MSN
Study questions benefit of FDA-cleared device for ADHD
The agency is currently reviewing the study findings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results